Skip to content

Author

Qing Wang

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Targeted protein degradation: mechanistic diversity, therapeutic expansion, and clinical translation.

This review provides a roadmap for translating TPD into transformative therapies and outlines key challenges including novel E3 ligase ligand discovery, tissue selectivity, and acquired resistance, and discusses how covalent fragment screening, artificial intelligence, and expanded E3 ligase repertoires will advance next-generation degraders to fulfill the promise of event-driven pharmacology.

Caiyu Wang, Zhibin Guo, Yufei Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.